Anatomic has developed RealMELO™, human iPSC derived melanocytes that can be differentiated and expanded in vitro. This allows researchers to study melanocyte maturation, melanin production, cosmetics development, pigmentation disorders, and melanoma progression. Additionally, iPSC technology enables the creation of disease-specific iPSC melanocyte models, facilitating the investigation of disease mechanisms, drug screening, and personalized medicine approaches.By harnessing the potential of human iPSC melanocytes, researchers can gain deeper insights into melanocyte biology and develop novel strategies for the diagnosis, treatment, and prevention of melanocyte-associated disorders. This approach not only saves time and resources but also offers a standardized and reproducible cellular model, enhancing the quality and reliability of research outcomes.​
​
-
1M per vial CAT#2020F1-1M
Rapid Differentiation Protocol
Anatomic's RealMELO™ offer a groundbreaking advancement in melanocyte research by providing a simplified and efficient 7-day protocol for their generation. This streamlined process allows researchers to generate high-quality melanocytes from human iPSCs in a significantly shorter timeframe compared to traditional methods.
Day 5
Day 7
RealMELO™ Resources
Find product manuals and other useful documentation for this product.
Reach out for more information on your assays of interest: support@anatomic.com.